Single Ascending Dose Study of PRX002 in Healthy Subjects

NCT02095171 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Parkinson's Disease

Interventions

DRUG: PRX002
OTHER: Placebo

Sponsor

Prothena Biosciences Limited

Collaborators

[object Object]